First non-injectable glucagon gets thumbs up from EMA

Baqsimi is administered nasally and is indicated for the treatment of severe hypoglycaemia in patients aged four years and older.
Baqsimi is administered nasally and is indicated for the treatment of severe hypoglycaemia in patients aged four years and older.